Your Guide to Reproductive Health Care Costs, Options and Economic Implications

Understand recent and upcoming changes in costs and access to reproductive care, as well as resources to manage them. This episode delves into the complex and ever-changing landscape of reproductive care costs. Hosts Sean Pyles and Sam Taube discuss the financial implications of recent high-profile court cases, including the overturning of Roe v. Wade and the Burwell v. Hobby Lobby decision, which significantly transformed insurance coverage for birth control. Sean and Sam break down the before-insurance costs of contraceptives and explain how a new over-the-counter birth control pill, Opill, could help make birth control more accessible.  Sam also speaks with Daily Garcia, a director at the Planned Parenthood Federation of America, about the costs and barriers associated with reproductive health care, particularly birth control and abortion. She explains how birth control and abortion costs can vary significantly based on type, insurance coverage, and individual circumstances. She also addresses the impact of state restrictions and resources available to help people overcome them. In their conversation, the Nerds discuss: costs of reproductive care, the overturning of Roe v. Wade, Burwell v. Hobby Lobby, Dobbs v. Jackson Women's Health Health Organization, access to birth control, contraceptives, over-the-counter birth control pills, the Opill, abortion costs, travel costs for abortion, insurance coverage, health insurance, the National Network of Abortion, the National Abortion Hotline, health care accessibility, systemic discrimination, neglected communities, patient navigators, court cases, bodily autonomy, health care legislation, mifepristone, misoprostol, and Planned Parenthood resources. To send the Nerds your money questions, call or text the Nerd hotline at 901-730-6373 or email [email protected]. Like what you hear? Please leave us a review and tell a friend. Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.